2017-2018 Session
Change SessionS.175 (Act 133)
An act relating to the wholesale importation of prescription drugs into Vermont
- Sponsor(s)
- Last Recorded Action
- Senate 5/12/2018 - Signed by Governor on May 16, 2018
Bill/Resolution Text
NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.
An act relating to the wholesale importation of prescription drugs into Vermont
Detailed Status
2017-2018 Legislative Session
Body | Date | Journal | Calendar | Location | Full Status |
---|
An act relating to the wholesale importation of prescription drugs into Vermont
Roll Call History
2017-2018 Legislative Session
Body | Date | Journal | Location | Full Status |
---|
Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.
An act relating to the wholesale importation of prescription drugs into Vermont
Committee Meetings
2017-2018 Legislative Session
Meeting Date | Committee |
---|
An act relating to the wholesale importation of prescription drugs into Vermont
Meeting Full List
2017-2018 Legislative Session
Thursday, January 18, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Sen. Tim Ashe, Sponsor
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Peter Welch, U.S. Congressman, Vermont
John Tracy, Field Representative, Office of Senator Patrick Leahy
Trish Riley, Executive Director, National Academy of State Health Policy
Friday, January 26, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:15 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Kevin Mullin, Chair, Green Mountain Care Board
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
Mark Hage, Member Benefits Director, Vermont-NEA
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Tuesday, January 30, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 11:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
- 11:15 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Discussion and Possible Mark-up
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Susan Barrett, Executive Director, Green Mountain Care Board
Friday, February 2, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 10:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Susan Barrett, Executive Director, Green Mountain Care Board
Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Tuesday, February 6, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- `
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Discussion, Possible Mark-up and Vote
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Wednesday, February 7, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:45 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Discussion and Possible Vote
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
Friday, February 9, 2018
- Committee(s):
- Senate Committee on Finance
- 2:30 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Walk thru of bill by drafter
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
Tuesday, February 13, 2018
- Committee(s):
- Senate Committee on Finance
- 2:30 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Possible Vote
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, February 23, 2018
- Committee(s):
- Senate Committee on Appropriations
- 1:00 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Sen. Claire Ayer
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, March 15, 2018
- Committee(s):
- House Committee on Health Care
- 10:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Walk-through with Legislative Counsel
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- 11:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Continue walk-through of the bill.
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Thursday, March 22, 2018
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Overview; Sec. 1 of the bill--importation of prescription drugs; fiscal note.
Sen. Tim Ashe, Sponsor
John Tracy, Field Representative, Office of Senator Patrick Leahy
Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
Peter Welch, U.S. Congressman, Vermont
Trish Riley, Executive Director, National Academy of State Health Policy
Jane Horvath, National Academy of State Health Policy
Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
Bernie Sanders, U.S. Senator
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, March 23, 2018
- Committee(s):
- House Committee on Health Care
- 8:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Background; prescription drug transparency; reports from the Attorney General's Office
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jill Abrams, Assistant Attorney General, Attorney General's Office
Wednesday, March 28, 2018
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Sec. 1, Importation of drugs, continued; Section 2, Bulk purchasing
Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
Theo Kennedy, Lobbyist, Vermont Retail Druggists
Jeff Hochberg, President, Vermont Retail Druggists
Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
- 10:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Section 6: "Gag rule"
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Jeff Hochberg, President, Vermont Retail Druggists
Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
Jamie Feehan, Lobbyist, CVS/Caremark
Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Thursday, March 29, 2018
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Testimony on Sections 3 and 4 --Health Insurance Plan Reporting; Impact of Prescription Drug Costs on Health Insurance Premiums
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Susan Barrett, Executive Director, Green Mountain Care Board
Kevin Mullin, Chair, Green Mountain Care Board
Wednesday, April 4, 2018
- Committee(s):
- House Committee on Health Care
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Committee discussion
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, April 5, 2018
- Committee(s):
- House Committee on Health Care
- 11:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Review draft and Committee discussion
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, April 11, 2018
- Committee(s):
- House Committee on Health Care
- 9:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Committee discussion
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- 10:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Discussion; follow-up from work group on current prescription drug pricing law.
Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
Jill Abrams, Assistant Attorney General, Attorney General's Office
Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
Bridget Morris, Lobbyist, Association for Accessible Medicines
Thursday, April 12, 2018
- Committee(s):
- House Committee on Ways and Means
- 9:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Thursday, April 12, 2018
- Committee(s):
- House Committee on Health Care
- 3:00 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Focus on drug importation & bulk purchasing
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 13, 2018
- Committee(s):
- House Committee on Health Care
- 11:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Committee discussion (S.262 discussion postponed to next week)
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- 2:15 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Final markup and possible vote. S.175 only.
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Time changed to 2:15 PM or after discussion on S.92
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Wednesday, April 18, 2018
- Committee(s):
- House Committee on Ways and Means
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- 3:15 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Al Gobeille, Secretary, Agency of Human Services
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Thursday, April 19, 2018
- Committee(s):
- House Committee on Ways and Means
- After the Floor
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Friday, April 20, 2018
- Committee(s):
- House Committee on Ways and Means
- 9:15 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
potential vote
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Friday, April 20, 2018
- Committee(s):
- House Committee on Health Care
- --After the Floor
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Bill As Recommended by House Ways and Means Committee.
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
https://legislature.vermont.gov/assets/Documents/2018/WorkGroups/House%20Health%20Care/Bills/S.175/S.175~House%20Ways%20and%20Means%20Committee~S.175,%20As%20Recommended%20by%20House%20Ways%20and%20Means%20Committee~4-20-2018.pdf
Rep. George W. Till
Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Tuesday, April 24, 2018
- Committee(s):
- House Committee on Health Care
- 1:00 PM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Committee discussion: Amendment from House Ways and Means
Rep. Mary S. Hooper, Sponsor of amendment
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Wednesday, April 25, 2018
- Committee(s):
- House Committee on Appropriations
- 11:30 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Rep. William J. Lippert, Chair, House Committee on Health Care
Thursday, April 26, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 8:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Committee Discussion
Thursday, May 3, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Monday, May 7, 2018
- Committee(s):
- Senate Committee on Health and Welfare
- 9:00 AM
-
S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
Jennifer Carbee, Legislative Counsel, Office of Legislative Council
Sen. Michael Sirotkin, Reporter, Senate Committee on Finance
Committee Documents
An act relating to the wholesale importation of prescription drugs into Vermont
Witnesses Who Testified
2017-2018 Legislative Session
House Committee on Appropriations
- Rep. William J. Lippert, Chair, House Committee on Health Care
House Committee on Health Care
- Jill Abrams, Assistant Attorney General, Attorney General's Office
- Sen. Tim Ashe, Sponsor
- Susan Barrett, Executive Director, Green Mountain Care Board
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
- Jamie Feehan, Lobbyist, CVS/Caremark
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Cory Gustafson, Commissioner, Department of Vermont Health Access (DVHA)
- Jeff Hochberg, President, Vermont Retail Druggists
- Nancy Hogue, Director of Pharmacy Services, Department of Vermont Health Access (DVHA)
- Rep. Mary S. Hooper, Sponsor of amendment
- Jane Horvath, National Academy of State Health Policy
- Theo Kennedy, Lobbyist, Vermont Retail Druggists
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America
- Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
- Bridget Morris, Lobbyist, Association for Accessible Medicines
- Kevin Mullin, Chair, Green Mountain Care Board
- Trish Riley, Executive Director, National Academy of State Health Policy
- Bernie Sanders, U.S. Senator
- Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
- Rep. George W. Till
- John Tracy, Field Representative, Office of Senator Patrick Leahy
- Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
- Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
- Peter Welch, U.S. Congressman, Vermont
House Committee on Ways and Means
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Al Gobeille, Secretary, Agency of Human Services
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Senate Committee on Appropriations
- Sen. Claire Ayer
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
Senate Committee on Finance
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Ashlie Van Meter, Senior Dir. State Gov't. Affairs, The Assoc. for Accessible Medicines
Senate Committee on Health and Welfare
- Sen. Tim Ashe, Sponsor
- Nate Awrich, Manager of Pharmacy Operations, University of Vermont Health Network
- Susan Barrett, Executive Director, Green Mountain Care Board
- Jennifer Carbee, Legislative Counsel, Office of Legislative Council
- David Englander, Senior Policy and Legal Advisor, Vermont Department of Health
- Jamie Feehan, Lobbyist, Property & Casualty Insurance Association and State Farm
- Devon Green, Vice President of Government Relations, Vermont Association of Hospitals and Health Systems
- Susan Gretkowski, Senior Government Affairs Strategist, MVP Healthcare
- Mark Hage, Member Benefits Director, Vermont-NEA
- Rebecca Heintz, General Counsel, Blue Cross/Blue Shield of Vermont
- Jeff Hochberg, President, Vermont Retail Druggists
- Theo Kennedy, Lobbyist, Vermont Retail Druggists
- Nolan Langweil, Senior Fiscal Analyst, Joint Fiscal Office
- Andrew MacLean, Lobbyist, Pharmaceutical Research and Manufacturers of America PhRMA
- Georgia Maheras, Director, Vermont Public Policy, Bi-State Primary Care Association
- Mary Kate Mohlman, Director of Health Care Reform, Agency of Human Services
- Kevin Mullin, Chair, Green Mountain Care Board
- Trish Riley, Executive Director, National Academy of State Health Policy
- Heather Shouldice, Lobbyist, Vermont Association of Chain Drug Stores
- Sen. Michael Sirotkin, Reporter, Senate Committee on Finance
- Sara Teachout, Director, Government, Public and Media Relations, Blue Cross/Blue Shield of Vermont
- John Tracy, Field Representative, Office of Senator Patrick Leahy
- Kathryn Becker Van Haste, Director of Health Policy Health, Veterans & Business Outreach, Senator Bernie Sanders
- Peter Welch, U.S. Congressman, Vermont
Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill. The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.
Fiscal Information
Fiscal Notes and Related Documents
- S.175 - An act relating to the wholesale importation of prescription drugs into Vermont
- S.175 An act relating to the wholesale importation of prescription drugs into Vermont, bulk purchasing, and the impact of prescription drug costs on health insurance premiums
No committee of conference members found for S.175 in the 2017-2018 Legislative Session.
An act relating to the wholesale importation of prescription drugs into Vermont
Committee of Conference Meetings
2017-2018 Legislative Session
Meeting Date | Committee |
---|
An act relating to the wholesale importation of prescription drugs into Vermont
Committee of Conference Meeting Full List
2017-2018 Legislative Session
No committee of conference meeting history found for S.175 in the 2017-2018 Legislative Session.
No committee of conference report found for S.175 in the 2017-2018 Legislative Session.
Act
- Signed into law 5/16/2018
- As Enacted (ACT 133)
- Act Summary
An act relating to the wholesale importation of prescription drugs into Vermont
Statutes Affected
2017-2018 Legislative Session
Statute |
---|
18 V.S.A. § 4651. Wholesale importation program for prescription drugs; design |
18 V.S.A. § 4652. Monitoring for anticompetitive behavior |
18 V.S.A. § 4653. Federal compliance |
18 V.S.A. § 4654. Program financing |
18 V.S.A. § 4655. Implementation provisions |
18 V.S.A. § 4656. Annual reporting |